Press Release Vanda Pharmaceuticals to Announce Second Quarter 2026 Financial Results on August 5, 2026 Jul 29
Press Release Vanda Pharmaceuticals Announces EMA Positive Opinion for Orphan Drug Designation of Imsidolimab for Generalized Pustular Psoriasis – A Milestone Recognition of GPP as a Distinct Rare Disease in Europe Jul 16
Press Release NEREUS™ Powers Forward: Sponsors No. 47 IndyCar Entry, Celebrating 47 Years Since Last New U.S. Motion Sickness Treatment Jul 15